United States· US:68982-349_46907c4a-5b69-fff9-8ecc-32c6ed0ed480
Fibryga
A medicinal product containing fibrinogen human, registered in United States by Octapharma USA Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FIBRINOGEN HUMAN
- Manufacturer
- Octapharma USA Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168982-349-01
- ndc1168982349011 BOTTLE, GLASS in 1 CARTON (68982-349-01) / 50 mL in 1 BOTTLE, GLASS (68982-349-81)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fibrinogen human in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomARTISS solution for sealant 10ml pre-filled syringesBaxter Healthcare Ltd
- BelgiumArtissBaxter
- IrelandFIBRYGA 2 g powder and solvent for solution for injection/infusionOctapharma (IP)
- SpainFIBCLOT 1,5 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE Y PARA PERFUSIONLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- NetherlandsFibclot 1,5 g, poeder en oplosmiddel voor oplossing voor injectie/infusieLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- GermanyFibclotLaboratoire Francais Du Fractionnement Et Des Biotechnologies
- FinlandFibclotLaboratoire Francais du Fractionnement et des Biotechnologies
- SwedenFibclot 1,5 g Pulver och vätska till injektions-/infusionsvätska, lösningLaboratoire français du Fractionnement et des Biotechnologies
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Fibclot, Fibryga
- Belgium · Fibclot, Fibryga
- Bulgaria · Fibryga, Хемокомплетан P
- Cyprus · Fibryga, Riastap
- Czechia · Fibryga, Haemocomplettan P
- Germany · Fibclot, Fibryga
- Denmark · Fibclot, Fibryga
- Estonia · Fibryga
- Spain · Fibclot, Fibryga
- Finland · Fibclot, Fibryga
- France · Clottafact, Fibryga
- United Kingdom (Northern Ireland) · Fibclot, Fibryga
- Greece · Fibclot, Riastap
- Croatia · Fibryga
- Hungary · Fibclot, Fibryga
- Ireland · Fibryga, Riastap
- Iceland · Fibryga, Riastap
- Italy · Fibriclotte, Fibryga
- Lithuania · Fibryga
- Luxembourg · Fibclot, Fibryga
- Latvia · Fibryga
- Malta · Fibryga, Riastap
- Netherlands · Fibclot, Fibryga
- Norway · Fibclot, Fibryga
- Poland · Fibryga, Riastap
- Portugal · Fibryga, Haemocomplettan
- Romania · Fibryga, Haemocomplettan P
- Sweden · Fibclot, Fibryga
- Slovenia · Fibrema, Prufibry
- Slovakia · Fibryga, Riastap
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e364682-6658-4b5d-a158-68fd5175ef0f GET /v1/drugs/9e364682-6658-4b5d-a158-68fd5175ef0f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "20",
"substance": "FIBRINOGEN HUMAN",
"productndc": "68982-349",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA125612",
"marketing_category": "BLA"
}See everything about fibrinogen human.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.